TY  - GEN
AU  - Yafour,Nabil
AU  - Beckerich,Florence
AU  - Bulabois,Claude Eric
AU  - Chevallier,Patrice
AU  - Daguindau,Étienne
AU  - Dumesnil,Cécile
AU  - Guillaume,Thierry
AU  - Huynh,Anne
AU  - Levrat,Stavroula Masouridi
AU  - Menard,Anne-Lise
AU  - Michallet,Mauricette
AU  - Pautas,Cécile
AU  - Poiré,Xavier
AU  - Ravinet,Aurelie
AU  - Yakoub-Agha,Ibrahim
AU  - Bazarbachi,Ali
TI  - [Preventative and therapeutic relapse strategies after allogeneic hematopoietic stem cell transplantation: Guidelines from the Francophone society of bone marrow transplantation and cellular therapy (SFGM-TC)]
SN  - 1769-6917
PY  - 2017///1228
KW  - Antineoplastic Agents
KW  - therapeutic use
KW  - Bortezomib
KW  - Central Nervous System Neoplasms
KW  - prevention & control
KW  - Genetic Markers
KW  - Hematologic Neoplasms
KW  - genetics
KW  - Hematopoietic Stem Cell Transplantation
KW  - Humans
KW  - Leukemia, Myelogenous, Chronic, BCR-ABL Positive
KW  - drug therapy
KW  - Lymphoma
KW  - Maintenance Chemotherapy
KW  - standards
KW  - Multiple Myeloma
KW  - Neoplasm, Residual
KW  - Prognosis
KW  - Protein Kinase Inhibitors
KW  - Recurrence
KW  - Retreatment
KW  - methods
KW  - Secondary Prevention
N1  - Publication Type: Journal Article; Practice Guideline; Review
UR  - https://doi.org/10.1016/j.bulcan.2017.05.009
ER  -